Experimental Ebola Vaccine Regimen Takes New Steps under HHS Program

As part of the international effort to develop vaccines that protect against Ebola and similar viruses, the advanced development of an experimental vaccine regimen will take new steps with support from an agreement between the U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (ASPR) and Crucell Holland, B.V., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, in the Netherlands.
Source: PHPartners.org - Category: Global & Universal Source Type: news